Agios Pharma (AGIO) PT Raised to $53 at RBC Capital
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Price: $33.09 -1.61%
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay raised the price target on Agios Pharma (NASDAQ: AGIO) to $53.00 (from $44.00) while maintaining a Outperform rating.
You May Also Be Interested In
- TD Cowen Assumes Agios Pharma (AGIO) at Buy
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
